Published in Cancer Causes Control on March 24, 2017
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol (2001) 12.72
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. Hum Pathol (2011) 5.53
Cancer Statistics, 2017. CA Cancer J Clin (2017) 4.77
Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol (1992) 4.48
Inflammation and cancer: an ancient link with novel potentials. Int J Cancer (2007) 4.19
Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst (1999) 3.64
Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncol (2011) 3.36
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst (2014) 2.40
Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand (2004) 2.26
Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer (2008) 2.14
Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology (2000) 2.07
Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int J Cancer (2009) 1.52
Inflammation and ovarian cancer. Cytokine (2012) 1.49
Ovarian cancer, the coagulation pathway, and inflammation. J Transl Med (2005) 1.33
Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (1995) 1.17
Pelvic inflammatory disease and tubo-ovarian abscess. Infect Dis Clin North Am (2008) 1.14
Population-based case-control study of ovarian cancer in Shanghai. Cancer Res (1989) 1.11
In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk. Gynecol Oncol (2012) 1.00
Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis. Cancer Prev Res (Phila) (2011) 0.93
Inflammation and ovarian cancer--current views. Ginekol Pol (2013) 0.91
Pelvic inflammatory disease and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev (1996) 0.89
Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors. Cancer Causes Control (2013) 0.87
Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol (2012) 0.84
Hereditary breast-ovarian cancer: clinical findings and medical management. Plast Surg Nurs (2007) 0.81
Diagnosis and treatment of epithelial ovarian cancer. Minerva Ginecol (2003) 0.78
Pelvic inflammation and the pathogenesis of ovarian cancer: a cohort study. Int J Gynecol Cancer (2014) 0.78
Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study. BMC Cancer (2016) 0.77
Is pelvic inflammatory disease a risk factor for ovarian cancer? Cancer Epidemiol Biomarkers Prev (2016) 0.77
The effect of contraceptive methods on reproductive tract infections risk: a cross-sectional study having a sample of 52,481 women. Arch Gynecol Obstet (2016) 0.76
Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management. Int J Womens Health (2016) 0.76
Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. Am J Epidemiol (2016) 0.75
Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study. Gynecol Oncol (2016) 0.75
Comparative Screening of Digestion Tract Toxic Genes in Proteus mirabilis. PLoS One (2016) 0.75